New Technology– category –
-
Cadmium-Free InP Quantum Dots Achieve Over 95% Quantum Yield, Rivaling CdSe-based QDs for Enhanced Lighting and Bioimaging Applications
ResearchGate (citing European Journal of Inorganic Chemistry) International Overview The synthesis and enhanced optical properties of cadmium-free (Cd-free) multinary quantum dots (QDs) have been reported, demonstrating that InP QDs hold... -
High-Performance Cadmium-Free InP/ZnSe/ZnS Quantum Dots Achieve 78% Near-IR PLQY, Promising for Bioimaging and Optoelectronics
Journal of the American Chemical Society USA Overview This research reports the successful synthesis of wurtzite InP/ZnSe/ZnS core/shell semiconductor quantum dots exhibiting bright near-infrared (NIR) emission. These high-performance, c... -
JNJ-1900 Nanoparticles Show Promising Phase II Results in Unresectable Stage III NSCLC, Marking a Turning Point for Nanomedicine in Clinical Application
Dove Medical Press (International Journal of Nanomedicine) USA Overview The year 2026 signifies a pivotal transition for nanomedicine, moving from preclinical promise to tangible clinical impact. Specifically, the functionalized hafnium ... -
Modern Dispersions Partners with HydroGraph to Scale Fractal Graphene Production, Boosting Material Strength by 20-70%
PR Newswire (via HydroGraph) USA Overview Modern Dispersions Inc. (MDI) has become a certified compounding partner for HydroGraph, significantly expanding commercial-scale fractal graphene masterbatch production in North America. MDI’s d... -
Photoactivated Nanomaterials Achieve 99% Bacterial Reduction in Antibiotic-Resistant Wounds, Revolutionizing Chronic Wound Care
ScienceDaily USA Overview Scientists have developed a novel smart wound care system utilizing photoactivated nanomaterials that effectively treats antibiotic-resistant chronic wounds. This innovative approach targets and eradicates resis... -
Cell and Gene Therapy’s Next Frontier: Overcoming Manufacturing, Commercial, and Clinical Infrastructure Challenges Beyond Scientific Discovery
Drug Discovery News USA Overview The primary challenge for cell and gene therapies is shifting from scientific discovery to building robust manufacturing, commercial, and clinical infrastructure. Issues like insufficient durability due t... -
Medyra Health Bolsters Therapeutic Development and Evaluation by Leveraging Real-World Evidence (RWE)
Medyra Health USA Overview Medyra Health outlines its RWE-focused therapeutic approach, emphasizing the generation of high-quality real-world evidence to enhance therapy evaluation and development. The company specializes in RWE study de... -
Penn Medicine Leads Cell and Gene Therapy Field, Pioneering Foundational Research for CAR T-Cell Therapies
Penn Medicine USA Overview Penn Medicine highlights its profound expertise in cell and gene therapies, including its foundational work in CAR T-cell therapy. The institution explains how these "biologics" target the root cause of illness... -
Alliance for Cancer Gene Therapy Appoints Jonathan S. Doctor and John Neamonitis to Board of Directors, Strengthening Research Funding Mission
PR Newswire USA Overview The Alliance for Cancer Gene Therapy (ACGT) announced the appointment of Jonathan S. Doctor and John Neamonitis to its Board of Directors. ACGT is a non-profit organization dedicated exclusively to funding scient... -
UC Riverside-Led Study: Gene Therapy Reverses Fragile X Deficits, Restoring Brain Activity and Improving Behavior in Mouse Model
UCR News - UC Riverside USA Overview A University of California, Riverside-led study demonstrated that a gene therapy designed to replace a missing brain protein successfully restored normal brain activity and improved behavior in a mous...
